General Interior Page
Re-envisioning radiation therapy:
THE FUTURE IS NOW
Program Success

Enloe Cancer Center – MRIdian Linear Accelerator
Enloe Cancer Center – Chico, CA
MDs: Sun K. Yi, MD; Sara Lim, MD; Steven Wahlen, MD; Jonathan Clark, MD; Lonny Trestrail, MS
Producer: Enloe Regional Cancer Center

Moffitt Cancer Center – MRI-Guided Patient Education Video
H. Lee Moffitt Cancer Center – Tampa, FL
MDs: Sarah Hoffe, MD; Louis Harrison, MD; Steve Rosenberg, MD
Producer: Moffitt Cancer Center and ViewRay (Michael Saracen)
Awards: 7 Telly Awards in 2021 for their MRI-guided radiation therapy patient education video.

Moffitt Cancer Center’s new technology tracks tumors in real-time; helps decrease radiation side effects
Meet Our Team

Scott Drake

Paul Ziegler

Amanda Sequira

James F. Dempsey, PhD

Zach Stassen

Rob Fuchs

Robert McCormack

Martin Fuss, MD
ViewRay In The News


GenesisCare Fort Myers – Dr. Rodney Ellis
- September 29, 2022

Providence Cancer Institute – Dr. Stephen Bader
- September 28, 2022
Lorem Ipsum Dolor
Radiation is delivered from a compact inline S-band 6 MV standing wave linac with side coupled cavities. The flattening filter free linac is designed to deliver 600 cGy/ min. The highlight of the MRIdian Linac design is the patented magnetic and RF shielding that isolates the workings of a linac and the MRI system from each other. A Linac emits RF energy that may interfere with the MRI image acquisition process and affect MRI image quality. MRIdian Linac uses copper shields enforced with carbon fiber for RF shielding. The combination of the materials reduces RF leakage from the linac to almost zero, ensuring zero impact on the MR image quality. The linac gantry is located in the central gap of the split super conducting magnet. ViewRay has developed specialized magnetic shielding technology consisting of concentric steel shells that create a central magnetic void at the linac components, in the otherwise uniform magnetic field of the MRI.
Lorem Ipsum Dolor
Radiation is delivered from a compact inline S-band 6 MV standing wave linac with side coupled cavities. The flattening filter free linac is designed to deliver 600 cGy/ min. The highlight of the MRIdian Linac design is the patented magnetic and RF shielding that isolates the workings of a linac and the MRI system from each other. A Linac emits RF energy that may interfere with the MRI image acquisition process and affect MRI image quality. MRIdian Linac uses copper shields enforced with carbon fiber for RF shielding. The combination of the materials reduces RF leakage from the linac to almost zero, ensuring zero impact on the MR image quality. The linac gantry is located in the central gap of the split super conducting magnet. ViewRay has developed specialized magnetic shielding technology consisting of concentric steel shells that create a central magnetic void at the linac components, in the otherwise uniform magnetic field of the MRI.
ViewRay, GenesisCare and the University of Oxford Announce Groundbreaking Compassionate Access Programme Now Open…
ViewRay, Inc. (Nasdaq: VRAY) announced today that the GenesisCare Foundation’s Compassionate Access Programme is now accepting patients for treatment on the MRIdian® MRI-Guided Radiation Therapy System. The program, in collaboration with the University of Oxford, is available to eligible National Health Service (NHS) patients with localized pancreatic cancer and is designed to improve access to precision radiotherapy in the United Kingdom,
Boston Globe COVID-19 Article Featuring MRIdian
Cancer doesn’t wait. Initially in March and April, there were significant unknowns, but we’ve been living with this for a few months. ... I feel very confident that we will provide the best care for patients and it’s safe for them to come into the hospital
Dr. Daniel Cagney, a radiation oncologist
Fabulas nostrum in per
MRIdian allows oncologists to visualize, adapt, and target using anatomical detail that
is simply unavailable with conventional IGRT technologies.
General Inquiries
[email protected]
Media Inquiries
[email protected]
Investor Relations
[email protected]
Medical Affairs
[email protected]
Customer Service
855-286-8875
General Inquires
440-703-3210